November 18, 2016

CAR T-Cell Therapy Moves Closer to FDA Approval
By Eric Bock
Currently, there are few options for patients with relapsed and treatment-resistant blood cancers. A new approach to immunotherapy might give those patients another option, said Dr. Carl June.

Former HHS Secretary Devotes Life to Diversity
By Dana Talesnik
Dr. Louis Wade Sullivan never forgot his roots. Throughout his distinguished career, the former HHS secretary, hematologist, professor and medical school president emeritus made great strides in health policy, medicine and education.
Five Questions with New NICHD Director
Dr. Diana Bianchi joined NIH as director of the National Institute of Child Health and Human Development on Nov. 7. She comes to NIH from the Floating Hospital for Children and Tufts Medical Center in Boston, where she served as founding executive director of the Mother Infant Research Institute and vice chair for pediatric research.
Journalists Learn Fundamentals of Cancer Research
By Robert Pines
“I don’t want you to leave this room as cynics, but as skeptics,” said NCI’s Dr. Barry Kramer while presenting to a room of 14 journalists about cancer screening and guidelines.